SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

ZATELLI, Maria Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.197
EU - Europa 5.135
AS - Asia 3.755
SA - Sud America 133
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 7
Totale 26.251
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.138
CN - Cina 1.792
DE - Germania 1.391
SG - Singapore 1.130
UA - Ucraina 1.087
IT - Italia 937
TR - Turchia 617
GB - Regno Unito 493
FI - Finlandia 357
SE - Svezia 262
PL - Polonia 203
RU - Federazione Russa 159
ID - Indonesia 130
BR - Brasile 120
FR - Francia 56
BE - Belgio 51
CA - Canada 51
NL - Olanda 42
AT - Austria 19
LT - Lituania 16
VN - Vietnam 16
CZ - Repubblica Ceca 10
EU - Europa 10
HK - Hong Kong 10
IN - India 9
IE - Irlanda 8
IR - Iran 8
CH - Svizzera 7
DK - Danimarca 7
JP - Giappone 7
MX - Messico 7
MA - Marocco 6
RO - Romania 6
AU - Australia 5
ES - Italia 5
MY - Malesia 5
KR - Corea 4
PK - Pakistan 4
AR - Argentina 3
BD - Bangladesh 3
EC - Ecuador 3
GR - Grecia 3
HU - Ungheria 3
IQ - Iraq 3
NP - Nepal 3
UZ - Uzbekistan 3
VE - Venezuela 3
BG - Bulgaria 2
CL - Cile 2
KE - Kenya 2
LV - Lettonia 2
NG - Nigeria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PE - Perù 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
ZA - Sudafrica 2
AL - Albania 1
CY - Cipro 1
DZ - Algeria 1
EG - Egitto 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
OM - Oman 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TW - Taiwan 1
Totale 26.251
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.085
Fairfield 1.882
Chandler 1.487
Ashburn 1.398
Jacksonville 1.264
Houston 1.195
Santa Clara 1.060
Singapore 858
Ann Arbor 842
Seattle 737
Wilmington 706
Cambridge 626
Izmir 409
Nanjing 374
Beijing 330
Princeton 311
Addison 276
Ferrara 238
Warsaw 203
San Diego 182
Boardman 179
Milan 176
Shanghai 172
Jakarta 130
New York 120
Shenyang 119
Helsinki 118
Nanchang 110
Los Angeles 101
Dearborn 100
Bremen 92
Hebei 85
Changsha 66
Tianjin 59
London 58
Mountain View 56
Jiaxing 55
Falls Church 52
Jinan 51
Washington 50
Brussels 44
Kunming 43
Redwood City 38
Munich 37
Norwalk 35
Falkenstein 33
Bologna 32
Frankfurt am Main 32
Guangzhou 31
Tappahannock 29
Toronto 29
Orange 26
Ningbo 25
Rome 23
San Mateo 23
Auburn Hills 22
Des Moines 19
Indiana 19
Hangzhou 18
Zhengzhou 18
Leawood 17
Taizhou 17
Dong Ket 16
Hefei 16
Nuremberg 15
Chicago 13
Lanzhou 11
Ottawa 11
Redmond 11
Augusta 10
Council Bluffs 10
Modena 10
Padova 10
Changchun 9
Hong Kong 9
Lappeenranta 8
Vienna 8
Brno 7
Chengdu 7
Ferrara di Monte Baldo 7
Haikou 7
Monmouth Junction 7
Naples 7
Ardabil 6
North Bergen 6
Philadelphia 6
São Paulo 6
Walnut 6
Yellow Springs 6
Dallas 5
Fort Worth 5
Kilburn 5
Mumbai 5
Prescot 5
Rio de Janeiro 5
Amsterdam 4
Ancona 4
Campinas 4
Chiswick 4
Dublin 4
Totale 19.317
Salva come PNG Salva come JPEG
Nome #
SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma 343
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 242
Igf-I influences everolimus activity in medullary thyroid carcinoma 171
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 169
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 165
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses 165
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 163
Applicability of laparoscopic approach to the resection of large adrenal tumours: a retrospective cohort study on 200 patients 162
Role of Ultrasonographic/Clinical Profile, Cytology, and BRAF V600E Mutation Evaluation in Thyroid Nodule Screening for Malignancy: A Prospective Study 161
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 157
Increase in Peripheral CD3-CD56brightCD16- Natural Killer Cells in Hashimoto's Thyroiditis Associated with HHV-6 Infection 156
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer 151
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression. 150
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 145
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization 144
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 144
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion. 143
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 142
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors 141
Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory 140
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 137
8th edition of the AJCC/TNM staging system of thyroid cancer: What to expect (ITCO#2) 137
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 137
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 136
X-linked acrogigantism syndrome: clinical profile and therapeutic responses 136
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 136
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines. 132
Levels of p27 sensitize to dual PI3K/mTOR inhibition 132
Functional characterization of a new deletion in CDKN1B 5'-UTR region 132
The cytotoxic effect of sunitinib on human bronchial carcinoid cell lines and primary cultures is counteracted by EGF and IGF-1 but not by VEGF 131
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 129
BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine needle aspiration biopsies. 128
Magmas, a Novel Over-Expressed Gene in Pituitary Rat Cell Lines and in Human Pituitary Adenomas: A New Pituitary Biomarker? 128
Pituitary side effects of old and new drugs. 127
VEGF autocrine secretion is enhanced by EGFR activation trough ERK1/2 phosphorylation in human adrenocortical carcinoma cell lines 127
Cerebral aneurysm and acromegaly: a case report 126
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 126
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 125
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 124
Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion 124
Epidermal growth factor pathway as a possible target in the medical therapy of bronchial carcinoids 124
Should aip gene screening be recommended in family members of FIPA patients with R16H variant? 123
Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto’s thyroiditis 122
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 122
The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells. 122
Radio-guided selective compartment neck dissection improves staging in papillary thyroid carcinoma: a prospective study on 345 patients with a 3-year follow-up. 122
HHV-6A in vitro infection of thyrocytes and T cells alters the expression of miRNA associated to autoimmune thyroiditis 122
Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study. 122
In vitro testing of new somatostatin analogs on pituitary tumor cells 121
RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease 121
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 120
Rare diseases in clinical endocrinology: a taxonomic classification system. 120
Acromegaly secondary to an incidentally discovered growth-hormone-releasing hormone secreting bronchial carcinoid tumour associated to a pituitary incidentaloma 119
Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation 119
Growth hormone excess promotes breast cancer chemoresistance 119
mTOR mediated IGF1 proliferative effects on a rat pituitary GH/PRL secreting pituitary adenoma cell line 119
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. 118
Magmas, a novel over-expressed gene in Pituitary rat cell lines and in human pituitary adenomas: a new pituitary bio marker? 118
Recettori della Somatostatina e Carcinoma Midollare della Tiroide: prospettive future. 117
Therapeutic concentrations of mitotane (o,p'-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model. 116
Runx2 mRNA Expression in the Tissue, Serum, and Circulating Non-Hematopoietic Cells of Patients with Thyroid Cancer 116
EGF and IGF1 affect sunitinib activity in BP-NEN: New putative targets beyond VEGFR? 116
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 115
Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame 115
null 114
Evaluation of bone markers and structure in subclinical Cushing’s syndrome 114
BRAFV600E analysis on fine needle aspiration biopsy increases diagnostic accuracy for papillary thyroid cancer in clinically unsuspected nodules 114
Somatostatin receptor subtype 1 selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. 114
miR-15a and miR-16-1 down-regulation in pituitary adenomas 114
MTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors 114
null 113
Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH) 113
Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells 113
Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. 112
null 111
Effects of two mTOR inhibitors on in-vitro models of GH-secreting pituitary adenomas 111
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 110
Utilization of luminescent technology to develop a kinase assay: Cdk4 as a model system 110
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 110
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 110
Inhibitory effect of dihydrotestosterone on human thyroid cell growth 109
Evaluation of the Role of BRAFV600E Somatic Mutation on Papillary Thyroid Cancer Disease Persistence: A Prospective Study 109
MicroRNAs and possible role in pituitary adenoma 108
Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects 108
Cushing in a Leaf: Endocrine Disruption From a Natural Remedy 108
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 107
Presenza di HHV-6 in campioni tiroidei di pazienti con malattie autoimmuni della tiroide 107
Adrenal cavernous hemangioma: a case report 107
null 106
Somatostatin, but not somatostatin receptor subtypes 2 and 5 selective agonists, inhibits calcitonin secretion and gene expression in the human medullary thyroid carcinoma cell line, TT. 106
Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line TT 106
Evidence for androgen receptor gene expression and growth inhibitory effect of dihydrotestosterone on human adrenocortical cells 106
Conventional and Nuclear Medicine Imaging in Ectopic Cushing's Syndrome: A Systematic Review 106
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression 105
Expression of functional KISS1 and KISS1R system is altered in human pituitary adenomas: evidence for apoptotic action of kisspeptin-10. 104
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study 104
Response to Pitoia and Niepomniszcze Thyroid 104
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 103
Growth hormone induces chemoresistance in breast cancer cells 103
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 102
Totale 12.747
Salva come PNG Salva come JPEG
Categoria #
all - tutte 145.828
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.723
Totale 152.551
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.672 0 0 0 0 0 0 0 481 358 498 255 80
2020/20213.348 271 234 199 449 206 341 101 368 98 477 429 175
2021/20222.754 113 256 179 54 118 160 129 151 114 223 266 991
2022/20233.186 321 277 130 435 467 440 168 266 385 26 165 106
2023/20242.076 151 193 103 57 138 315 56 454 58 47 49 455
2024/20253.267 206 165 605 202 929 796 221 143 0 0 0 0
Totale 26.748